Obesity

Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the cholesterol-HDL-glucose (CHG) index and its obesity indicators: a prospective cohort study with survival prediction model

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

The CHG index and its obesity indicators are significant predictors of all-cause and cardiovascular mortality in hypertensive patients, and CHG-WHtR exhibits better prognostic performance in terms of mortality risk.

Study context

Population
Hypertensive participants in the China Health and Retirement Longitudinal Study (CHARLS)
Participants
4,661 participants
Exposure
CHG index and its obesity indicators as predictors of mortality
Outcome
All-cause and cardiovascular mortality
Methodological detailssurvival machine learning models (Cox, Cox-LASSO, Survival XGBoost), competing-risk (Fine-Gray) regression for cardiovascular mortality
  • Survival machine learning models (Cox, Cox-LASSO, Survival XGBoost)
  • Competing-risk (Fine-Gray) regression for cardiovascular mortality

Main finding

As reported in the abstract

CHG-WHtR per 1-SD increase, all-cause mortality: HR

2.060

95% CI 1.852–2.292P < 0.001

CHG-WHtR per 1-SD increase, cardiovascular mortality: HR

2.020

95% CI 1.816–2.247P < 0.001

Observational data: associations, not effects.

Further findings

Discrimination of Cox-LASSO model · 3, 5 and 7 years

Test C-index
0.920 (95% CI 0.878-0.962)
tdAUC range across 3, 5 and 7 years
0.851-0.916

Reclassification after adding CHG indices

Continuous net reclassification index (NRI) range
0.349-0.496
Integrated discrimination improvement (IDI) range
0.024-0.040

Dose-response shape

L-shaped relationship with all-cause mortality (non-linear P < 0.001)
L-shaped relationship with cardiovascular mortality (non-linear P < 0.001)

Original publication

Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model. Cardiovasc Diabetol. Published 5 August 2026. doi:10.1186/s12933-026-03281-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.